Home › Marginal Zone Lymphoma › New Jersey
Pag-aaral pangklinika para sa Marginal Zone Lymphoma sa New Jersey
9 pag-aaral para sa Marginal Zone Lymphoma ang naghahanap ng mga kalahok sa mga site sa New Jersey.
Mga Lungsod sa New Jersey
Opisyal na teksto ng pag-aaral (English)
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04840602A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07101328A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memoral Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07231952A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07029217A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- START New Jersey, East Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07424833Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
- Rutgers Cancer Institute of New Jersey, New Brunswick
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT04792502SynKIR-310 for Relapsed/Refractory B-NHL
- Rutgers Cancer Institute, New Brunswick
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT06544265Study of SGR-1505 in Mature B-Cell Neoplasms
- Regional Cancer Care Associates, Hackensack
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.